title: New melanoma treatments: a panacea or a Pandora's box?
authors.forename: Kavita
authors.initials: K
authors.lastname: Mariwalla
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D006801:Humans; D007211:Indoles / Q000008:administration & dosage; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D009367:Neoplasm Staging; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D013449:Sulfonamides / Q000008:administration & dosage; D016019:Survival Analysis; D000077484:Vemurafenib
chemical_list: D000911:Antibodies, Monoclonal; D007211:Indoles; D000074324:Ipilimumab; D013449:Sulfonamides; D000077484:Vemurafenib